Global Cell Therapy Pipeline Analysis
Naperville, IL -- (SBWire) -- 06/02/2014 --Reportstack, provider of premium market research reports announces the addition of Global Cell Therapy Pipeline Analysis market report to its offering
Global Cell Therapy Pipeline Analysis by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Cell Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases.
This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Cell Therapy based drug development process. Following parameters for each drug profile in development phase are covered in Global Cell Therapy Pipeline Analysis research report:
Drug Profile Overview
Alternate Names for Drug
Active Indication
Phase of Development
Mechanism of Action
Brand Name
Orphan Designation by Indication, Country & Organisation
Country for Clinical Trial
Owner / Originator/ Licensee/Collaborator
Administrative Route Drug Class
ATC Codes
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/156601/global-cell-therapy-pipeline-analysis.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###
Media Relations Contact
Roger Campbell
Director of Marketing
http://www.reportstack.com
View this press release online at: http://rwire.com/513888